This evidence-based best-practices program will foster discussion and debate among experts dedicated to improving the care of patients with cancer pain. Using brief summary didactics, peer-to-peer conversations, and case studies shaped by audience input, three recognized thought leaders in the field—each with established expertise in the diagnosis and individualized treatment of various cancer pain syndromes—will participate in an interactive, case-based discussion. The expert panel will share interpretive insights into practice guidelines as well as their own clinical strategies for assessing and differentially diagnosing breakthrough pain (BTP).
Recommendations for optimizing opioid-based therapy in diverse patient types and the class-wide Risk Evaluation and Mitigation Strategy for transmucosal immediate-release fentanyl medications will be addressed. Clinical cases will address pressing, real-world issues faced by oncology nurses, while incorporating reviews of patient-directed educational resources, self-management tips, and caregiver-support strategies.
Register here. This activity is supported by an educational grant from Teva CNS.
